OTC, supplements & other. Every registered pack in the UAE with published prices, agents and manufacturers; the price spread between brands; the same medicine in India, the US and the EU; and same‑class alternatives.
Unit price to public, same form and strength, registered brands only. Green = cheapest. The spread is the gap a class‑level tender or formulary switch can usually close.
India: India brand MRP (median of 2) ₹900.00 ($10.714) per tablet at 300mg. US prices are not published by FDA; EU prices are national. Ask us for a landed‑cost benchmark.
₹650.92–900.00 per unit across 4 priced packs. MRP as printed on pack (indicative, open dataset 2024); combinations listed after single‑ingredient brands. Showing 4 of 4.
| Brand | Manufacturer | Strength | Pack | MRP ₹ | ₹ / unit |
|---|---|---|---|---|---|
| Nuparp 200 Tablet | Zydus Cadila | 200mg | bottle of 60 tablets | ₹39,055.00 | ₹650.92 |
| Bdparib 200 Tablet | BDR Pharmaceuticals Internationals Pvt | 200mg | bottle of 60 tablets | ₹45,000.00 | ₹750.00 |
| Nuparp 300 Tablet | Zydus Cadila | 300mg | bottle of 60 tablets | ₹47,301.00 | ₹788.35 |
| Bdparib 300 Tablet | BDR Pharmaceuticals Internationals Pvt | 300mg | bottle of 60 tablets | ₹54,000.00 | ₹900.00 |
Not yet classified.
None are Active on the UAE register at this release.
No published UAE price at this release.
No matching‑strength India reference price is available for a per‑unit comparison.
See the register tab.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Data: DoH Abu Dhabi Shafafiya drug list (2 Nov 2026); FDA NDC Directory and Orange Book (Sept–Nov 2026); NPPA and PMBI Jan Aushadhi (Nov 2026); EMA (Nov 2026); WHO ATC/DDD 2026; Consulting Wallah class repository. For information only; verify with the regulator before purchase or dispensing. No prescribing advice. © Consulting Wallah — CC BY‑NC‑ND; bulk extraction not permitted.